Advertisement
"ARIA is a powerful oncology information system that manages the clinicalprocesses unique to radiotherapy treatments for cancer," said Corey Zankowski,Varian's senior director for product management. "In addition to providing acomplete electronic medical record for oncology, ARIA is exceptional atrecording and verifying the numerous treatment parameters and instruction setsrequired for complex radiotherapy treatments. Varian is committed to creatinga completely open environment and ensuring connectivity between ARIA and mostcommonly-used radiation delivery devices, including proton treatment systems.As such, Varian is pleased to be developing, with the support of Still River,an interface with the Monarch250 proton therapy system."
Advertisement
"It is Varian's aim to bring the familiar workflow, look and feel of ARIAinto the proton environment, to ease the transition of staff from conventionalradiotherapy to proton therapy," adds James DeFilippi, Varian's businessmanager for integrated proton solutions.
Still River Systems will provide technical assistance to Varian engineers,who will develop the interface to allow important "record and verify"functionality across the two systems.
"We are developing the Monarch250 proton therapy system to supportexisting clinical processes. The Monarch250 ARIA interface will allow cancercenters to integrate proton therapy within their existing radiation therapypractices," adds Skip Rosenthal, PhD, Still River Systems vice president,clinical systems.
Any new ARIA interface that facilitates "record and verify" functions withnew radiotherapy delivery technologies are subject to 510(k) clearance by theFDA, and would need such clearance prior to any clinical deployment.
About Still River Systems
Still River Systems, based in Littleton, Massachusetts, is dedicated toproviding physicians and their patients access to high quality, cost-effectiveproton therapy solutions, and to help establish this superior treatmentmodality as a standard of care for patients worldwide. Still River Systemsis developing the Monarch250, an affordable, precise and compact protontherapy system for cancer treatment. This system has not yet been cleared bythe FDA for commercial use in clinical therapy. For more information on StillRiver Systems and the Monarch250 Proton Therapy System, please call 978-540-1500 or visit their website @ http://www.StillRiverSystems.com.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world'sleading manufacturer of medical devices and software for treating cancer andother medical conditions with radiotherapy, radiosurgery, proton therapy, andbrachytherapy. The company supplies informatics software for managingcomprehensive cancer clinics, radiotherapy centers and medical oncologypractices. Varian is a premier supplier of tubes and digital detectors forX-ray imaging in medical, scientific, and industrial applications and alsosupplies X-ray imaging products for cargo screening and industrial inspection.Varian Medical Systems employs approximately 4,600 people who are located atmanufacturing sites in North America and Europe and in its 60 sales andsupport offices around the world. For more information, visithttp://www.varian.com/.
FORWARD LOOKING STATEMENTS
This press release contains certain forward-looking statements within themeaning of the Private Securities Litigation Reform Act of 1995, whichprovides a "safe harbor" for these types of statements. These forward-lookingstatements regarding future business, events, plans, objectives, expectati